https://www.selleckchem.com/pr....oducts/elamipretide-
A substantial number of patients showed new comorbidities over 10 years. Positivity for ACPA was confirmed as a robust predictor of long-term outcome. We report a very mild 10-year outcome of a large cohort of patients with early RA diagnosed in the early 2000s, which was much better than results for a previous cohort of patients who were recruited in 1993. This current favourable outcome may be related to more intensive care for real-life patients. We report a very mild 10-year outcome of a large cohort of patients with ea
Like
Comment
Share
